Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000406) titled 'Clinical efficacy evaluation of He Shu Xiao Ji Pills in preventing and treating liver injury related to standardized treatment of primary liver cancer' on Feb. 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Condition:
Primary liver cancer
2C12.0
Intervention:
Control group:Carry out standardized Western medical treatment in accordance with the "Diagnosis and Treatment Specifications for Primary Liver Cancer" (2017 Edition)
Recruitment Status: Not Recruiting
Phase: New Treatment Measure Cli...